Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990
In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”
Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita
New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed
Sullivan Confirmation Hearing Set For Feb. 1
USC Cancer Center Plans Expansion, Gets New Name
AACR Receives Record Number of Abstracts
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - Group chairs propose funding strategy to jump-start correlative studies
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Karen Knudsen to leave ACS
